Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Taiwan Styrene Monomer Corporation (1310.TW)
Taipei, TW
Taiwan Styrene Monomer Corporation, through its various subsidiaries, is a key player in the global manufacturing and supply of essential chemical substances. The company's product portfolio encompasses styrene monomer, para-diethyl benzene, toluene, methyl benzene, hydrogen, and ethyl benzene, which are distributed across Taiwan, the United States, and other international markets. Its business operations are segmented into three distinct areas: Plastics, Investment, and a general 'Other' category. These chemical offerings are integral to a wide array of industries, including electrical appliances, machinery, electronics, automotive production, and packaging. The corporation's primary customers are producers of polystyrene, acrylonitrile-butadiene-styrene (ABS) resins, and synthetic rubber. Beyond its core chemical manufacturing, Taiwan Styrene Monomer Corporation boasts a diversified service offering. This includes the wholesale distribution of medical apparatus and the provision of specialized piping engineering solutions. The company also extends into real estate, overseeing the development and leasing of residential and industrial properties, and operates hotel establishments. Further diversifying its activities, it manufactures electrical components and provides consulting expertise in fields such as education, information technology, software, and data storage. Established in 1979, the company's corporate headquarters are situated in Taipei City, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.01% | -7.21% | -20.60% | -11.63% | -9.42% | -9.93% | -10.74% | -52.07% | -52.64% | -47.33% | -72.58% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-24.1% Q1'26: -4.8% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-90.3% Q1'26: -176.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-0.8% Q1'26: -0.3% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-8.3% Q1'26: +7.1% (vs Q1'25)
-
ROIC Chemicals: +3.4%-8.9% Q1'26: +7.7% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×-3.34× Q1'26: 1.67× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
13.12B
est: 18.57B (-29.3%)
|
14.07B
est: 13.34B (+5.5%)
|
14.75B
est: 14.61B (+1.0%)
|
15.38B
est: 16.08B (-4.3%)
|
12.22B
est: 12.97B (-5.8%)
|
8.11B
est: 7.59B (+6.9%)
|
11.71B
est: 7.97B (+47.0%)
|
9.54B
est: 9.53B (+0.1%)
|
11.42B
est: 10.69B (+6.8%)
|
8.67B
est: 8.67B (+0.0%)
|
8.23B
8.23B – 8.23B
-5.1% YoY
|
| EBITDA |
1.16B
est: 159.69M (+623.7%)
|
2.09B
est: 114.76M (+1,723.5%)
|
1.64B
est: 125.66M (+1,201.6%)
|
1.91B
est: 138.26M (+1,282.8%)
|
1.32B
est: 111.51M (+1,084.8%)
|
626.78M
est: 65.26M (+860.5%)
|
206.49M
est: 68.51M (+201.4%)
|
-271.17M
est: 81.98M (-430.8%)
|
-183.89M
est: -184.93M (+0.6%)
|
-452.93M
est: -150.01M (-201.9%)
|
-142.36M
-142.36M – -142.36M
+5.1% YoY
|
| EBIT |
943.51M
est: -312.19M (+402.2%)
|
1.80B
est: -224.36M (+902.2%)
|
1.28B
est: -245.66M (+622.1%)
|
1.52B
est: -270.29M (+662.5%)
|
934.79M
est: -218.00M (+528.8%)
|
373.88M
est: -127.58M (+393.1%)
|
-43.80M
est: -133.94M (+67.3%)
|
-549.95M
est: -160.27M (-243.1%)
|
-459.79M
est: -457.42M (-0.5%)
|
-722.32M
est: -371.04M (-94.7%)
|
-352.13M
-352.13M – -352.13M
+5.1% YoY
|
| Net Income |
693.82M
est: 707.35M (-1.9%)
|
1.41B
est: 1.43B (-1.2%)
|
1.06B
est: 1.26B (-16.3%)
|
1.22B
est: 2.54B (-52.1%)
|
882.07M
est: 1.07B (-17.3%)
|
287.52M
est: -81.82M (+451.4%)
|
104.60M
est: 279.77M (-62.6%)
|
-462.18M
est: -332.56M (-39.0%)
|
-380.85M
est: -263.94M (-44.3%)
|
-724.62M
est: -512.03M (-41.5%)
|
-190.03M
-190.03M – -190.03M
+62.9% YoY
|
| SGA |
324.74M
est: 367.37M (-11.6%)
|
392.05M
est: 264.01M (+48.5%)
|
376.83M
est: 289.08M (+30.4%)
|
405.38M
est: 318.06M (+27.5%)
|
299.72M
est: 256.53M (+16.8%)
|
208.20M
est: 150.13M (+38.7%)
|
216.38M
est: 157.62M (+37.3%)
|
198.64M
est: 188.59M (+5.3%)
|
203.16M
est: 200.94M (+1.1%)
|
179.49M
est: 162.99M (+10.1%)
|
154.69M
154.69M – 154.69M
-5.1% YoY
|
| EPS |
1.31
est: 1.34 (-2.2%)
|
2.67
est: 2.71 (-1.3%)
|
2.00
est: 2.39 (-16.3%)
|
2.30
est: 4.81 (-52.2%)
|
1.67
est: 2.02 (-17.3%)
|
0.55
est: -0.16 (+454.8%)
|
0.20
est: 0.53 (-62.3%)
|
-0.88
est: -0.63 (-39.7%)
|
-0.72
est: -0.50 (-44.0%)
|
-1.37
est: -0.97 (-41.2%)
|
-0.36
-0.36 – -0.36
+62.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.01% | 16.1K | 0.42% |
| 2 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 401.2K | 0.06% |
| 3 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 167.9K | 0.39% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 173.5K | 0.29% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 119.5K | 0.28% |
| 6 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 28.3K | 0.26% |
| 7 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 12.6K | 0.48% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.40M | 0.06% |
| 9 | Vanguard ESG International Stock ETF VSGX | 0.00% | 17.7K | 0.10% |
| 10 | Vanguard Total International Stock ETF VXUS | 0.00% | 1.70M | 0.05% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Wen-Yuan Lin | Chairperson & Chief Executive Officer | 10M | male |
| Ming Nan Chen | Financial Officer and Corporation Governance Officer | — | — |
| Yan-Chun Chen | Accounting Supervisor | — | female |
| Yi-Yuan Zheng | Vice President | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1310.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
